MarketLens
Sign Up

Why is Eli Lilly Betting on Shingles Vaccines

3 months ago
SHARE THIS ON:

Why is Eli Lilly Betting on Shingles Vaccines

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News3 weeks ago

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Healthcare stocks lagged the market this year, but 11 names, including Eli Lilly and McKesson, look ready to gain as investors rotate back into the sector.
Stock News4 weeks ago

Lilly, Resilience to invest $750 million in US drug manufacturing expansion

Eli Lilly and Resilience will invest $750 million to expand US pharmaceutical manufacturing capacity, strengthening the domestic medicine supply chain, Resilience announced Thursday.
Stock News1 months ago

Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs

Eli Lilly acquired a neuroscience asset for $2.8B, expanding beyond its core GLP-1 franchise as competition in that market intensifies.
Stock News1 months ago

Should You Buy Eli Lilly Stock? Here's My Honest Take.

Eli Lilly's business is booming, but a bear case exists against the pharma stock, creating a mixed outlook for investors.

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

This AI Energy Stock Is Up Nearly 2,000% in the Last Two Years. Could It Be Nvidia's Next Big Investment?

Stock News2 hours ago

Microsoft's stock seals its longest winning streak of the year as AI software fears fade

Stock News2 hours ago

Stock Market Today, Aug. 28: Marvell Slides 10% on Softer Fiscal 2028 Guidance and Google Deal Timing

Stock News2 hours ago

This AI Fund Is Crushing QQQ, and Nvidia Is Barely 2% of It

Stock News3 hours ago

4 Space Catalysts — and Where Capital Flows Next